6Chang SY,Yud S.Wang J,et al.Histopathological effects and recovery rate of rat bladder following intravesical instillation of thiotepa.doxorubicin and mitomycin C.Br J Urol,1990.66:623.
7Giesbers A.van Helsdingen P,Kramer A.Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin C.Br J Urol,1989.63:176.
8Soloway MS.Treatment of the superficial bladder cancer with intravesical mitomycin C:analysis of immediate and long term response in 70 patients.J Urol.1985.134:1107.
2Babjuk M, Burger M, Zigeuner R,打 al.EAU guidelines on nonmuscle-invasive urothelial carcinoma of the bladder: update 2013 [J].Eur Urol,2013,64(4):639-653.
3Anastasiadis A, de Reijke TM Best practice in the treatment of nonmuscle invasive bladder cancer [J]. Ther Adv Urol,2012,4(1):13-32.
4Barlow LJ, Benson MC. Experience with newer intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer[J].Curr Urol Rep,2013,14(2): 65-70.
5GriffinJG, HolzbeierleinJ. Sideeffects of perioperativeintravesical treatment and treatment strategies for these side ef￡ects[J].Urol Clin North Am,2013,40(2) : 197-210.
